Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2431516rdf:typepubmed:Citationlld:pubmed
pubmed-article:2431516lifeskim:mentionsumls-concept:C0040135lld:lifeskim
pubmed-article:2431516lifeskim:mentionsumls-concept:C1882726lld:lifeskim
pubmed-article:2431516lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:2431516lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:2431516lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:2431516pubmed:issue1lld:pubmed
pubmed-article:2431516pubmed:dateCreated1987-1-7lld:pubmed
pubmed-article:2431516pubmed:abstractTextMetabolites were measured in freeze-clamped livers from rats that had been maintained for 3 weeks on a stock diet supplemented with 0.1% 5,5'-diphenylthiohydantoin (DPTH). Compared with control animals, DPTH-treated animals had lower levels of phosphoenolypyruvate and 3-phosphoglycerate and elevated ratios of [ATP]/[ADP][Pi] and [NADP+]/[NADPH], suggesting mild hypothyroidism. Conversely, the administration of thyroxine (T4) for 5 days to animals fed the control diet resulted in elevated levels of phosphoenolpyruvate, 3-phosphoglycerate, and ketone bodies and lowered ratios of [ATP]/[ADP][Pi] and [NADP+]/[NADPH], consistent with the known effects of thyroid hormones on liver tissues. In animals simultaneously treated with DPTH and T4, the effects of thyroxine on the [NADP+]/[NADPH] ratio and the levels of phosphoenolypyruvate, 2-phosphoglycerate and ketone bodies were reversed. However, the calculated free cytoplasmic [ATP]/[ADP][Pi] ratio and the calculated cytochrome c3+/cytochrome c2+ ratio did not return to control values. This suggests that those actions of thyroid hormone which are mediated by potentiation of adrenergic effects are reversed by DPTH. These actions include a decrease in peripheral lipolysis, a reduction of the free cytoplasmic [NADP+]/[NADPH] ratio, and an apparent inhibition of the pyruvate kinase reaction, but DPTH apparently does not reverse the effects of thyroid hormone on mitochondrial O2 consumption and ATP generation.lld:pubmed
pubmed-article:2431516pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2431516pubmed:languageenglld:pubmed
pubmed-article:2431516pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2431516pubmed:citationSubsetIMlld:pubmed
pubmed-article:2431516pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2431516pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2431516pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2431516pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2431516pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2431516pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2431516pubmed:statusMEDLINElld:pubmed
pubmed-article:2431516pubmed:monthSeplld:pubmed
pubmed-article:2431516pubmed:issn0748-2337lld:pubmed
pubmed-article:2431516pubmed:authorpubmed-author:TobinR BRBlld:pubmed
pubmed-article:2431516pubmed:authorpubmed-author:MehlmanM AMAlld:pubmed
pubmed-article:2431516pubmed:authorpubmed-author:SchafferW TWTlld:pubmed
pubmed-article:2431516pubmed:authorpubmed-author:VeechRRlld:pubmed
pubmed-article:2431516pubmed:issnTypePrintlld:pubmed
pubmed-article:2431516pubmed:volume1lld:pubmed
pubmed-article:2431516pubmed:ownerNLMlld:pubmed
pubmed-article:2431516pubmed:authorsCompleteYlld:pubmed
pubmed-article:2431516pubmed:pagination45-55lld:pubmed
pubmed-article:2431516pubmed:dateRevised2011-10-3lld:pubmed
pubmed-article:2431516pubmed:meshHeadingpubmed-meshheading:2431516-...lld:pubmed
pubmed-article:2431516pubmed:meshHeadingpubmed-meshheading:2431516-...lld:pubmed
pubmed-article:2431516pubmed:meshHeadingpubmed-meshheading:2431516-...lld:pubmed
pubmed-article:2431516pubmed:meshHeadingpubmed-meshheading:2431516-...lld:pubmed
pubmed-article:2431516pubmed:meshHeadingpubmed-meshheading:2431516-...lld:pubmed
pubmed-article:2431516pubmed:meshHeadingpubmed-meshheading:2431516-...lld:pubmed
pubmed-article:2431516pubmed:meshHeadingpubmed-meshheading:2431516-...lld:pubmed
pubmed-article:2431516pubmed:meshHeadingpubmed-meshheading:2431516-...lld:pubmed
pubmed-article:2431516pubmed:meshHeadingpubmed-meshheading:2431516-...lld:pubmed
pubmed-article:2431516pubmed:meshHeadingpubmed-meshheading:2431516-...lld:pubmed
pubmed-article:2431516pubmed:meshHeadingpubmed-meshheading:2431516-...lld:pubmed
pubmed-article:2431516pubmed:meshHeadingpubmed-meshheading:2431516-...lld:pubmed
pubmed-article:2431516pubmed:meshHeadingpubmed-meshheading:2431516-...lld:pubmed
pubmed-article:2431516pubmed:meshHeadingpubmed-meshheading:2431516-...lld:pubmed
pubmed-article:2431516pubmed:meshHeadingpubmed-meshheading:2431516-...lld:pubmed
pubmed-article:2431516pubmed:year1985lld:pubmed
pubmed-article:2431516pubmed:articleTitleInhibition of the effects of thyroid hormone on rat liver by 5,5'-diphenylthiohydantoin.lld:pubmed
pubmed-article:2431516pubmed:publicationTypeJournal Articlelld:pubmed